We report a rare case of hepatocellular carcinoma in native liver in a case of biliary atresia. The patient was a 38-year-old female with three children who had an aggressive tumor, resulting in her subsequent death. We also review 14 reports, published previously in the English language medical literature, concerning hepatocellular carcinoma originating from native liver in biliary atresia cases and discuss the possible etiology, and propose more careful follow up for the patients with biliary atresia who suffer from repetitive cholangitis and/or experience the child delivery. Hepatocellular carcinoma (HCC) is rarely seen in cirrhotic liver of biliary atresia, with only 20 cases having been reported in the English language medical literature [1e14]. Almost all hepatocellular carcinomas seen in biliary atresia are slow growing and not very aggressive tumors, with half of them incidentally found in extracted livers at autopsy or after liver transplantation.
a b s t r a c t
We report a rare case of hepatocellular carcinoma in native liver in a case of biliary atresia. The patient was a 38-year-old female with three children who had an aggressive tumor, resulting in her subsequent death. We also review 14 reports, published previously in the English language medical literature, concerning hepatocellular carcinoma originating from native liver in biliary atresia cases and discuss the possible etiology, and propose more careful follow up for the patients with biliary atresia who suffer from repetitive cholangitis and/or experience the child delivery. Hepatocellular carcinoma (HCC) is rarely seen in cirrhotic liver of biliary atresia, with only 20 cases having been reported in the English language medical literature [1e14] . Almost all hepatocellular carcinomas seen in biliary atresia are slow growing and not very aggressive tumors, with half of them incidentally found in extracted livers at autopsy or after liver transplantation.
Here we report on a 38-year-old female patient with biliary atresia, who had long suffered from repetitive cholangitis and finally died of a hepatocellular carcinoma in her native liver.
Case
A 38-year-old female patient was referred to our department because an hepatic tumor was suspected after a high serum alphafetoprotein (AFP) level, and as subsequently demonstrated by abdominal computed tomography (CT) scan. She had previously been admitted to our institute because of prolonged jaundice during her early infantile years. As a 71-days-old baby, after several examinations, the patient was diagnosed with biliary atresia type III and underwent portoenterostomy with a bile drainage stoma. After the operation, her jaundice subsided and since then, she has been followed at our outpatient clinic. Periodic blood tests showed mild liver dysfunction and she underwent splenectomy at 24 years of age because of worsening hypersplenism caused by prolonged portal hypertension. The patient had borne three children, delivering them at 30, 35, and 38 years of age. She was followed at our outpatient clinic every three months and at 38 years of age abdominal ultrasound were taken and a hepatic mass, 3 cm in diameter, was found in the posterior segment of the right lobe (Fig. 1a) which was first thought to be focal nodular hyperplasia. But a blood test showed a high AFP level (2632.8 ng/mL). The mass grew rapidly to 6 cm by two weeks which was ascertained by abdominal CT scans, and hepatocellular carcinoma was strongly suspected (Fig. 1b and c) . Serological tests were negative for hepatitis B antigen and hepatitis C antibody. A month later, a laparotomy revealed a bloody ascites in the abdominal cavity, which suggested a spontaneous rupture of the tumor. The posterior segment of the right lobe ( Fig. 2a) was resected and the tumor was macroscopically removed. The pathological diagnosis was a moderately differentiated hepatocellular carcinoma ( Fig. 2b and c) ; background liver tissue showed severe fibrosis and a paucity of bile ducts. Three months later, a recurrence of the tumor was detected in hypertrophic segment 1, which was subsequently resected again (Fig. 3a) . After the second operation, the persistence of a high fever was noted, together with multiple lung metastases as demonstrated by lung CT scans; tumor recurrence was also demonstrated in the residual liver. Sorafenib was administered but tumor progression could not be controlled (Fig. 3b) , and a year after the first operation, the patient died after tumor rupture and hepatic failure.
Discussion
Hepatocellular carcinoma is relatively rare in childhood and is often seen in cirrhotic liver with chronic viral hepatitis. Conversely, HCC is rarely seen in liver with biliary atresia, with only 20 cases previously reported in the English language medical literature [1e14] ( Table 1 ). Our case is the twenty-first case to be reported.
Briefly in summary, five out of the 20 HCC in biliary atresia cases had been autopsied [1e4,7] , and reported in the days prior to the liver transplantation era. Of the 20 cases, eight were male and 11 were female, with one of unknown sex, and all were under the age of 20. AFP was elevated in 10 out of 15 cases, including our reported case [5, 7, 9, 10, 12, 13] . Given the data on chronic viral infection, such as hepatitis B or hepatitis C, is quite restrictive, only three cases were checked for infection, including our case, and all were found to be negative [7, 11] . Liver transplantation was successfully performed in 15 cases. In 10 cases, including autopsied cases, HCC was incidentally found in the liver.
Our case is strikingly uncharacteristic for HCC in bilary atresia in some respects: For instance, tumor growth was very rapid and aggressive, which was quite different from that of previously reported cases. The patient was followed every three months with blood tests and the tumor was found in its early stages, but was too aggressive to prevent death. Additionally, the patient's age (38 years) made her the oldest among the reported cases. The patient had a cirrhotic liver for a long time; this is a well-known risk factor for HCC, but in biliary atresia, HCC is rarely a complication. Moreover, the patient had suffered from repetitive cholangitis for a long time, suggesting that chronic inflammation might have triggered the observed tumorigenesis. The patient had also experienced child birth three times, suggesting hormonal changes may have caused an imbalance of homeostasis in liver metabolism, which might also be related to the etiology of HCC tumorigenesis [15] .
Considering her medical history, we should respond more rapidly for the tumor resection in this case, otherwise the only chance of saving the patient was liver transplantation. But tumor progression was very rapid in this patient, which did not allow for the selection of an appropriate donor in time for a living related liver transplantation.
Conclusion
A 38-year-old patient with biliary atresis could not be saved because of an extremely aggressive HCC, in spite of periodic followup. Recently, the number of long-term survivors of biliary atresia in native liver has increased. However, the establishment of follow-up schedules in these patients are lacking. Our case is a valuable lesson for considering such a scheme in future. We now recommend more careful follow up for the patients with biliary atresia who suffer from repetitive cholangitis and/or experience the child delivery. To be more concrete, periodic AFP measurement and ultrasound examination are important and once AFP elevation appears the early abdominal CT or MRI be recommended. 
